the risk of jaw bone damage while taking Fosamax or other bisphosphonates
Lots of worried patients are asking about the risk of jaw bone damage while taking Fosamax or other bisphosphonates.
Questions about osteonecrosis of the jaw have really picked up since we alerted you to this rare problem last year.
The incidence is very low for patients taking ORAL Fosamax, Actonel, or Boniva for osteoporosis. It's probably less than 1 case per 100,000 patients per year.